Skip to main content
    N

    NextCure  Inc (NXTC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.70
    +0.02 (+0.30%)

    Market Cap: $30.59M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    NextCure  Inc (NXTC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    NextCure (NXTC) has a market cap of $30.59M and an enterprise value of $21.86M. Its share count is up 98.41% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 28.53% below the market cap, as cash exceeds debt.

    Market Cap$30.59M
    Enterprise Value$21.86M
    Latest price (Nov 17, 2026)$6.70

    Key Dates

    The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 3, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 50.92% a year over 2 years.

    Shares Outstanding5.31M
    Shares Change (YoY)+98.41%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+50.92%

    Price Statistics

    The stock is down 32.19% over 52 weeks and trades 12.98% above its 50-day average.

    Beta (1Y)2.18
    52-Week Change-32.19%
    1-Month Change+18.17%
    3-Month Change-1.18%
    6-Month Change-26.62%
    5-Year Change-93.61%
    Total Return (1Y)-32.19%
    Total Return (3Y CAGR)-24.16%
    Total Return (5Y CAGR)-37.57%
    Return vs SPY (1Y)-44.56%
    Max Drawdown (1Y)-88.79%
    Max Drawdown (3Y)-94.65%
    Sharpe Ratio (1Y)-0.24
    Correlation with SPY (1Y)0.18
    50-Day Average$5.93
    200-Day Average$7.49
    52-Week Range$1.55 to $15.74
    RSI (14 Days)58.2
    Average Volume (20 Days)57.07K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.31x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.31x
    Quick Ratio2.31x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -744.50% over the last 12 months, against a 5-year average of -74.80%.

    Return on Equity (ROE)-744.50%
    Return on Assets (ROA)-422.37%
    Return on Capital Employed (ROCE)-744.50%
    ROE (5Y Average)-74.80%
    ROA (5Y Average)-59.66%

    Scores

    NXTC has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$365.00K
    Operating Income-$41.88M
    Pretax Income-$40.97M
    Net Income-$40.97M
    EBITDA-$40.21M
    EBIT-$40.97M
    Reported EPS (TTM)-$6.19

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 56.70% of the $9.70M in total assets.

    Cash and Equivalents$8.73M
    Total Debt$0
    Net Cash$8.73M
    Net Cash Per Share$1.64
    Working Capital$5.50M
    Shareholder Equity$5.50M
    Book Value Per Share$1.04
    Total Assets$9.70M
    Total Liabilities$4.20M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$42.79M
    FCF Per Share-$9.34
    Depreciation and Amortization$1.08M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-54.99%
    Tangible Book Per Share Growth (2Y CAGR)-54.99%

    Revenue and profit by year

    Dividends and Yields

    NXTC does not pay a dividend.

    Buyback Yield-66.19%
    Shareholder Yield-66.19%

    Stock Splits

    The last split was a 1-for-12 reverse split on Jul 14, 2025.

    Last Split DateJul 14, 2025
    Split TypeReverse split
    Split Ratio1:12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About NXTC

    What is NXTC's market cap?

    NextCure has a market cap of $30.59M. Its enterprise value, which adds debt and subtracts cash, is $21.86M.

    How many shares of NXTC are outstanding?

    NextCure has 5.31M shares outstanding. The count is up 98.41% from a year earlier.

    Does NXTC pay a dividend?

    No. NextCure does not pay a dividend.

    How much debt does NXTC have?

    NextCure has $0 of total debt and $8.73M of cash and equivalents, a net cash position of $8.73M.